Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:BSBRNYSE:FSICNYSE:RFNASDAQ:RPRX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBSBRBanco Santander (Brasil)$5.40+0.4%$5.07$3.75▼$5.77$20.10B0.76484,925 shs371,959 shsFSICFS Investment$21.17-1.0%$6.13$5.32▼$8.24$5.06B0.951.39 million shs985,458 shsRFRegions Financial$21.47-2.7%$20.92$17.74▼$27.96$19.34B0.968.19 million shs10.90 million shsRPRXRoyalty Pharma$34.84-1.2%$32.82$24.05▼$35.38$19.59B0.483.61 million shs3.52 million shs10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBSBRBanco Santander (Brasil)0.00%+4.75%+0.75%+17.26%+8.65%FSICFS Investment-0.98%-0.61%+1.44%-1.26%+3.32%RFRegions Financial0.00%-2.75%-4.35%+0.13%+14.89%RPRXRoyalty Pharma0.00%+3.14%+5.19%+6.32%+28.09%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBSBRBanco Santander (Brasil)3.8096 of 5 stars1.35.03.30.02.80.04.4FSICFS InvestmentN/AN/AN/AN/AN/AN/AN/AN/ARFRegions Financial4.8604 of 5 stars3.32.05.03.42.91.72.5RPRXRoyalty Pharma4.721 of 5 stars3.61.03.33.73.41.71.9Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBSBRBanco Santander (Brasil) 2.50Moderate Buy$5.35-0.93% DownsideFSICFS Investment 0.00N/AN/AN/ARFRegions Financial 2.52Moderate Buy$25.8020.15% UpsideRPRXRoyalty Pharma 3.25Buy$47.3335.86% UpsideCurrent Analyst Ratings BreakdownLatest FSIC, RF, BSBR, and RPRX Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/11/2025BSBRBanco Santander (Brasil)UBS GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeNeutral ➝ Buy6/3/2025RFRegions FinancialStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$24.005/23/2025RFRegions FinancialTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingHold ➝ Hold5/21/2025RFRegions FinancialJefferies Financial GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy ➝ Hold$24.005/16/2025RPRXRoyalty PharmaMorgan StanleySubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$51.005/15/2025RFRegions FinancialTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$31.005/14/2025RFRegions FinancialCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy4/22/2025RFRegions FinancialTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$24.00 ➝ $21.004/22/2025RFRegions FinancialThe Goldman Sachs GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $25.004/21/2025RFRegions FinancialKeefe, Bruyette & WoodsSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOutperform ➝ Outperform$28.00 ➝ $26.004/21/2025RFRegions FinancialStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetOverweight ➝ Overweight$26.00 ➝ $24.00(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBSBRBanco Santander (Brasil)$49.01B0.41$0.76 per share7.15$6.18 per share0.87FSICFS Investment$419.31M12.07$3.36 per share6.30$9.30 per share2.28RFRegions Financial$7.12B2.71$2.33 per share9.20$17.82 per share1.20RPRXRoyalty Pharma$2.26B8.65$4.39 per share7.94$17.94 per share1.94Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBSBRBanco Santander (Brasil)$1.89B$0.816.677.610.73N/AN/AN/A7/30/2025 (Estimated)FSICFS Investment$181.98M$0.8325.5126.462.21-3.73%9.57%5.31%N/ARFRegions Financial$1.89B$2.0811.078.661.9320.20%12.83%1.32%7/18/2025 (Estimated)RPRXRoyalty Pharma$858.98M$1.8524.037.172.3137.94%24.40%14.01%8/6/2025 (Estimated)Latest FSIC, RF, BSBR, and RPRX EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025RPRXRoyalty Pharma$0.99$1.06+$0.07$0.41$724.69 million$839.00 million4/17/2025Q1 2025RFRegions Financial$0.51$0.54+$0.03$0.51$1.84 billion$1.81 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBSBRBanco Santander (Brasil)$0.183.33%N/A22.22%N/AFSICFS Investment$0.763.59%N/A91.57%N/ARFRegions Financial$1.004.66%N/A48.08%12 YearsRPRXRoyalty Pharma$0.882.53%N/A47.57%5 YearsLatest FSIC, RF, BSBR, and RPRX DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date4/16/2025RFRegions Financialquarterly$0.255.21%6/2/20255/2/20257/1/20254/21/2025RPRXRoyalty Pharmaquarterly$0.222.7%5/16/20255/16/20256/10/20254/17/2025BSBRBanco Santander (Brasil)$0.04633.97%4/23/20254/24/20255/19/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBSBRBanco Santander (Brasil)0.250.300.30FSICFS Investment0.751.941.94RFRegions Financial0.370.840.83RPRXRoyalty Pharma0.641.441.44Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBSBRBanco Santander (Brasil)14.53%FSICFS Investment29.47%RFRegions Financial79.39%RPRXRoyalty Pharma54.35%Insider OwnershipCompanyInsider OwnershipBSBRBanco Santander (Brasil)0.06%FSICFS Investment1.07%RFRegions Financial0.29%RPRXRoyalty Pharma18.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBSBRBanco Santander (Brasil)52,6003.72 billion3.72 billionOptionableFSICFS InvestmentN/A239.15 millionN/ANot OptionableRFRegions Financial20,100898.93 million905.87 millionOptionableRPRXRoyalty Pharma80562.24 million477.83 millionOptionableFSIC, RF, BSBR, and RPRX HeadlinesRecent News About These CompaniesMerit Financial Group LLC Invests $252,000 in Royalty Pharma plc (NASDAQ:RPRX)June 13 at 3:43 AM | marketbeat.comGAMMA Investing LLC Buys 77,751 Shares of Royalty Pharma plc (NASDAQ:RPRX)June 13 at 3:18 AM | marketbeat.comRoyalty Pharma (NASDAQ:RPRX) Reaches New 52-Week High - Here's WhyJune 12 at 12:19 PM | marketbeat.comHandelsbanken Fonder AB Decreases Stock Position in Royalty Pharma plc (NASDAQ:RPRX)June 12 at 5:48 AM | marketbeat.comRPRX Q1 Earnings Call: Flat Revenue, Portfolio Expansion, and Capital Return InitiativesJune 10, 2025 | msn.comPallas Capital Advisors LLC Acquires 8,113 Shares of Royalty Pharma plc (NASDAQ:RPRX)June 10, 2025 | marketbeat.comWedge Capital Management L L P NC Takes Position in Royalty Pharma plc (NASDAQ:RPRX)June 8, 2025 | marketbeat.comRoyalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare ConferenceJune 4, 2025 | globenewswire.comAmeriprise Financial Inc. Reduces Position in Royalty Pharma plc (NASDAQ:RPRX)June 4, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock?June 2, 2025 | finance.yahoo.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Purchased by California State Teachers Retirement SystemMay 31, 2025 | marketbeat.comMackenzie Financial Corp Buys 9,313 Shares of Royalty Pharma plc (NASDAQ:RPRX)May 31, 2025 | marketbeat.com111 Capital Purchases New Shares in Royalty Pharma plc (NASDAQ:RPRX)May 30, 2025 | marketbeat.comLansforsakringar Fondforvaltning AB publ Makes New Investment in Royalty Pharma plc (NASDAQ:RPRX)May 30, 2025 | marketbeat.com9,329 Shares in Royalty Pharma plc (NASDAQ:RPRX) Purchased by GF Fund Management CO. LTD.May 27, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 350,315 Shares of Royalty Pharma plc (NASDAQ:RPRX)May 27, 2025 | marketbeat.comTidal Investments LLC Lowers Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)May 27, 2025 | marketbeat.comSquarepoint Ops LLC Sells 242,051 Shares of Royalty Pharma plc (NASDAQ:RPRX)May 26, 2025 | marketbeat.comMIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Grows Stock Holdings in Royalty Pharma plc (NASDAQ:RPRX)May 26, 2025 | marketbeat.comRoyalty Pharma plc (NASDAQ:RPRX) Shares Sold by Janus Henderson Group PLCMay 26, 2025 | marketbeat.comUniversity of Texas Texas AM Investment Management Co. Buys New Stake in Royalty Pharma plc (NASDAQ:RPRX)May 25, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesCoca-Cola Stock Has Momentum, PepsiCo May Be the Better BuyBy Chris Markoch | May 29, 2025View Coca-Cola Stock Has Momentum, PepsiCo May Be the Better BuyWorkday Stock Price Implosion: An Automatic Buy for AI InvestorsBy Thomas Hughes | May 26, 2025View Workday Stock Price Implosion: An Automatic Buy for AI Investors3 Different Ways to Add Gold to Your PortfolioBy Chris Markoch | May 29, 2025View 3 Different Ways to Add Gold to Your PortfolioNike’s Amazon Expansion Could Signal a Turnaround in 2025By Gabriel Osorio-Mazilli | May 30, 2025View Nike’s Amazon Expansion Could Signal a Turnaround in 2025Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in MayBy Leo Miller | June 12, 2025View Mid-Cap Marvels: 3 Stocks That Crushed Sales Estimates in MayFSIC, RF, BSBR, and RPRX Company DescriptionsBanco Santander (Brasil) NYSE:BSBR$5.40 +0.02 (+0.37%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$5.40 +0.00 (+0.09%) As of 06/13/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Banco Santander (Brasil) S.A., together with its subsidiaries, provides various banking products and services to individuals, small and medium enterprises, and corporate customers in Brazil and internationally. The company operates through Commercial Banking and Global Wholesale Banking segments. It offers local loans, commercial financing options, development bank funds, and cash management services; export and import financing, guarantees, structuring of asset services. In addition, the company provides financing and advisory services for infrastructure projects and capital markets instruments, as well as offers equity transactions and mergers and acquisitions services. Further, it offers foreign exchange products, derivatives, and investments to institutional investors, corporate clients, and individuals. Additionally, the company provides research services, as well as offers brokerage services for corporate, institutional, and individual investors. Furthermore, it provides deposits and other bank funding instruments, and debit and credit cards. The company provides financial services and products to its customers through multichannel distribution network comprising branches, mini-branches, ATMs, call centers, Internet banking, and mobile banking. Banco Santander (Brasil) S.A. was incorporated in 1985 and is headquartered in São Paulo, Brazil. The company operates as a subsidiary of Banco Santander, S.A.FS Investment NYSE:FSICFS KKR Capital Corp. is an externally managed, non-diversified, closed-end management investment and finance company that invests primarily in the debt securities of private middle market U.S. companies. Its objectives are to generate current income and, to a lesser extent, long-term capital appreciation. The company was founded by Michael Craig Forman on December 21, 2007 and is headquartered in Philadelphia, PA.Regions Financial NYSE:RF$21.47 -0.61 (-2.75%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$21.51 +0.04 (+0.17%) As of 06/13/2025 06:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Regions Financial Corporation, a financial holding company, provides banking and bank-related services to individual and corporate customers. It operates through three segments: Corporate Bank, Consumer Bank, and Wealth Management. The Corporate Bank segment offers commercial banking services, such as commercial and industrial, commercial real estate, and investor real estate lending; equipment lease financing; deposit products; and securities underwriting and placement, loan syndication and placement, foreign exchange, derivatives, merger and acquisition, and other advisory services. It serves corporate, middle market, and commercial real estate developers and investors. The Consumer Bank segment provides consumer banking products and services related to residential first mortgages, home equity lines and loans, consumer credit cards, and other consumer loans, as well as deposits. The Wealth Management segment offers credit related products, and retirement and savings solutions; and trust and investment management, asset management, and estate planning services to individuals, businesses, governmental institutions, and non-profit entities. It also provides investment and insurance products; low-income housing tax credit corporate fund syndication services; and other specialty financing services. The company was founded in 1971 and is headquartered in Birmingham, Alabama.Royalty Pharma NASDAQ:RPRX$34.84 -0.43 (-1.22%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$34.66 -0.18 (-0.50%) As of 06/13/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic institutions, research hospitals and not-for-profits, small and mid-cap biotechnology companies, and pharmaceutical companies. Its portfolio consists of royalties on approximately 35 commercial products and 14 development-stage product candidates that address various therapeutic areas, such as rare disease, cancer, neuroscience, immunology, respiratory, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
